2026 Yusuke Furukawa: Biology and Biochemistry Researcher – H-Index, Publications & Awards

Discipline name	D-Index	World Ranking	Current World Ranking	National Ranking	Current National Ranking	Publications	Citations
Biology and Biochemistry	56	14560	13379	1031	961	245	9929

Overview

Yusuke Furukawa is affiliated with Jichi Medical University in Japan and has contributed extensively to the fields of Medicine and Biochemistry, Genetics and Molecular Biology. Their research primarily focuses on molecular biology and hematology, with significant work in health, toxicology and mutagenesis, pulmonary and respiratory medicine, as well as radiology, nuclear medicine and imaging.

The main topics covered in Yusuke Furukawa's work include:

Multiple Myeloma Research and Treatments
Protein Degradation and Inhibitors
Air Quality and Health Impacts
Occupational and Environmental Lung Diseases
Occupational Exposure and Asthma
Monoclonal and Polyclonal Antibodies Research
Peptidase Inhibition and Analysis

Yusuke Furukawa has collaborated frequently with several coauthors, including:

Jiro Kikuchi
Shigeyuki Hirai
Hideki Senoh
Kyohei Misumi
Kenji Takanobu

The scientist has published in several prominent journals. The most frequent publication venues include:

European Heart Journal
bioRxiv (Cold Spring Harbor Laboratory)
Scientific Reports
The Journal of Toxicological Sciences
Particle and Fibre Toxicology

Among recent papers authored or coauthored by Yusuke Furukawa are:

"Splicing- and demethylase-independent functions of LSD1 in zebrafish primitive hematopoiesis," 2020, Scientific Reports
"Molecular basis of clonal evolution in multiple myeloma," 2020, International Journal of Hematology
"Pulmonary dust foci as rat pneumoconiosis lesion induced by titanium dioxide nanoparticles in 13-week inhalation study," 2022, Particle and Fibre Toxicology
"Novel hepatotoxicity biomarkers of extracellular vesicle (EV)-associated miRNAs induced by CCl4," 2020, Toxicology Reports
"No evidence for carcinogenicity of titanium dioxide nanoparticles in 26-week inhalation study in rasH2 mouse model," 2022, Scientific Reports

Best Publications

The product of the retinoblastoma susceptibility gene has properties of a cell cycle regulatory element.

James A. DeCaprio;John W. Ludlow;Dennis Lynch;Yusuke Furukawa

1179
Citations
Signal transduction of the human granulocyte-macrophage colony- stimulating factor and interleukin-3 receptors involves tyrosine phosphorylation of a common set of cytoplasmic proteins

Yuzuru Kanakura;Brian Druker;Stephen A. Cannistra;Yusuke Furukawa

382
Citations
In vitro cytotoxic effects of a tyrosine kinase inhibitor STI571 in combination with commonly used antileukemic agents

Yasuhiko Kano;Miyuki Akutsu;Saburo Tsunoda;Hiroyuki Mano

350
Citations
The retinoblastoma-susceptibility gene product becomes phosphorylated in multiple stages during cell cycle entry and progression.

James A. Decaprio;Yusuke Furukawa;Florence Ajchenbaum;James D. Griffin

317
Citations
cdc2 gene expression at the G1 to S transition in human T lymphocytes

Yusuke Furukawa;Helen Piwnica-Worms;Timothy J. Ernst;Yuzuru Kanakura

284
Citations
Bortezomib overcomes cell-adhesion-mediated drug resistance through downregulation of VLA-4 expression in multiple myeloma

K Noborio-Hatano;J Kikuchi;M Takatoku;R Shimizu

242
Citations
A Janus Kinase Inhibitor, JAB, Is an Interferon-γ–Inducible Gene and Confers Resistance to Interferons

Hiroshi Sakamoto;Hideo Yasukawa;Masaaki Masuhara;Shyu Tanimura

219
Citations
Apaf-1 is a mediator of E2F-1-induced apoptosis.

Yusuke Furukawa;Noriko Nishimura;Yutaka Furukawa;Masaaki Satoh

180
Citations
Expression and state of phosphorylation of the retinoblastoma susceptibility gene product in cycling and noncycling human hematopoietic cells

Y Furukawa;J A DeCaprio;A Freedman;Y Kanakura

179
Citations
Histone deacetylases are critical targets of bortezomib-induced cytotoxicity in multiple myeloma

Jiro Kikuchi;Taeko Wada;Rumi Shimizu;Tohru Izumi

151
Citations
Phosphorylation of Bcl-2 Protein by CDC2 Kinase during G2/M Phases and Its Role in Cell Cycle Regulation

Yusuke Furukawa;Satsuki Iwase;Jiro Kikuchi;Yasuhito Terui

150
Citations
The Expression of ST2 Gene in Helper T Cells and the Binding of ST2 Protein to Myeloma-Derived RPMI8226 Cells

Ken Yanagisawa;Yoshiyuki Naito;Kenji Kuroiwa;Takao Arai

136
Citations
Direct Transcriptional Activation of Human Caspase-1 by Tumor Suppressor p53

Sanjeev Gupta;Vegesna Radha;Yusuke Furukawa;Ghanshyam Swarup

129
Citations
HDAC inhibitors augment cytotoxic activity of rituximab by upregulating CD20 expression on lymphoma cells.

R. Shimizu;J. J. Kikuchi;T. Wada;K. Ozawa

126
Citations
Ablation of neutral cholesterol ester hydrolase 1 accelerates atherosclerosis.

Motohiro Sekiya;Jun-ichi Osuga;Jun-ichi Osuga;Shuichi Nagashima;Taichi Ohshiro

124
Citations
Treatment of myeloid leukemic cells with the phosphatase inhibitor okadaic acid induces cell cycle arrest at either G1/S or G2/M depending on dose

Yuji Ishida;Yusuke Furukawa;James A. Decaprio;Masaki Saito

122
Citations
Lineage-specific regulation of cell cycle control gene expression during haematopoietic cell differentiation

Yusuke Furukawa;Jiro Kikuchi;Mitsuru Nakamura;Satsuki Iwase

116
Citations
Phosphorylation-mediated EZH2 inactivation promotes drug resistance in multiple myeloma

Jiro Kikuchi;Daisuke Koyama;Taeko Wada;Tohru Izumi

116
Citations
Transcriptional Modulation Using HDACi Depsipeptide Promotes Immune Cell-Mediated Tumor Destruction of Murine B16 Melanoma

Takashi Murakami;Atsuko Sato;Nicole A L Chun;Mayumi Hara

114
Citations
Efficient ejection of H3(+) from hydrocarbon molecules induced by ultrashort intense laser fields.

Kennosuke Hoshina;Yusuke Furukawa;Tomoya Okino;Kaoru Yamanouchi

113
Citations